COPD and other respiratory diseases often come with health complications, both big and small. One of the more serious complications of COPD is acute respiratory failure, a medical emergency that occurs when you experience a sudden and serious drop in lung function.

Daily medications are a primary life-line for people with COPD, and a necessary part of life for people with asthma and other respiratory diseases. In fact, most COPD patients have to follow a strict treatment regimen and take several different medications every day just to keep their symptoms under control.

If you or someone you love has COPD, then you might have heard about a treatment known as pulmonary rehabilitation. This treatment is essentially a breathing and exercise training program specifically designed for people with COPD and other respiratory problems that make it difficult to breathe.

Consider this hypothetical scenario: you have a COPD exacerbation and your shortness of breath suddenly gets much worse than usual. You call your doctor to see what you should do, and she tells you to go to the hospital right away.

If you are like most people with COPD, you've probably experienced at least some degree of pain in your chest and ribs. This kind of pain can come in a variety of forms, including muscle aches, rib soreness, chest tightness, and general feelings of discomfort.

If you keep up with our blog here at LPT Medical, you’ll know that last week we crowned the Inogen One G5 with the title “The Best Portable Oxygen Concentrator of 2020.” As you can imagine, we don’t take this title lightly.

If you have COPD, your number one responsibility as a patient is to do what your doctor says and take all your medications as prescribed. This might sound simple on the surface but, in reality, it's much easier said than done.

Oxygen therapy, pulmonary rehabilitation, and inhaled medication are the most common treatment options for COPD. They’re proven to significantly reduce respiratory symptoms like coughing, wheezing and shortness of breath, while simultaneously reducing the rate at which COPD progresses. 

All medication prescribed to patients in the United States is approved by the Center for Drug Evaluation and Research (CDER), a branch of the U.S. Food and Drug Administration (FDA). This program acts as a watchdog for all genetic and biological therapeutic drugs being tested throughout the country, ensuring that only safe and effective ones are administered to the general public.